Avia Pharma
Avia Pharma at a glance
Avia Pharma (“Avia”) is a leading Sweden-based OTC and Rx pharmaceutical company with presence in the Nordics and Germany.
Avia distributes medically positioned products within dermatology, allergy, women’s health, urology and everyday health products and has since foundation in 2017 successfully executed on its strategy to build its portfolio of brands through a combination of M&A, in-licensing of additional products and growing market share across the portfolio.
Avia facts
Pharmaceuticals
December 2023
Stockholm, Sweden
Jacob Calmvik (CEO)
Jonas Karlander (CFO)
Carolina Oscarius-Dahl
Magnus Edlund
Gustav J. Lundgren
Olga Court-Payen
Emilia Staaf
124
Investment Thesis
- Exposure to large and fundamentally attractive OTC and Rx market niches
- Existing portfolio comprising high-quality products
- Organic and semi-organic profitable growth initiatives across existing and new products
- Platform for M&A growth across Northern European countries
UN SDG Goals
Other portfolio companies
Oticon Medical
Oticon Medical is a global hearing healthcare company specializing in bone-anchored hearing solutions (BAHS), a niche segment addressing conductive hearing loss.
Qufora
Qufora is a fast-growing Danish medical technology product company with focus on transanal irrigation (“TAI”) products and collecting devices
Avia Pharma
Avia is a leading North European OTC/Rx platform